How we help

Bringing manufacturing in-house.

Moving from a CDMO to your own site changes your operating surface more than your org chart suggests.

The moment

You are about to own more than a building.

The decision is made. Maybe the CDMO relationship stopped scaling, maybe the economics turned, maybe you acquired a site. Either way you are about to own manufacturing, and the project plan you have is mostly about the building.

The building is the visible part. What is less visible is that you are also about to own materials management, production scheduling, batch records, deviations, release, warehouse operations, and a quality system that now has to cover all of it — most of which previously arrived as a line item on someone else's invoice.

What usually goes wrong

The facility gets a plan. The processes get whatever is left.

The operating processes are scoped as an afterthought to the facility. Capital projects have gravity. The site gets a plan, a budget, and a program manager; the processes that will run inside it get whatever attention is left, usually starting far too late.

The CDMO's implicit knowledge is not inventoried. Your partner has been doing things you do not have written down, because you were buying an outcome rather than a process. Some of that becomes your obligation the day you take it in-house, and the list is longer than anyone expects.

Systems are extended rather than reconsidered. The finance system that ran an asset-light company gets pointed at a manufacturing operation because replacing it feels like too much on top of everything else. Sometimes that is right. It should be a decision with evidence behind it, not a default.

What good looks like

The full surface, mapped before the first batch.

Operations. The full surface is mapped before the first batch — materials, scheduling, execution, release, warehouse, distribution — with owners named and the handoffs between them agreed.

Regulatory. You know which of your new processes carry GxP weight, what documentation they require, and what your quality system has to grow to cover. And, just as important, which ones do not need it.

Capital. Inventory valuation, standard costing, and margin visibility work from day one. A lot of companies discover in the first quarter of owned manufacturing that they cannot actually cost a batch.

Global. If the site will supply more than one market, that is designed in rather than discovered.

The first two weeks

We map what changes — not the facility, the operating surface.

We map what changes — not the facility plan, the operating surface. What you currently buy as a service and will shortly own as a process. Then we assess whether your current systems and quality system can carry it, and what has to be true before the first batch runs.

A self-check

Six questions worth answering before the first batch.

  1. Do you have a written list of everything your CDMO does that you will have to do yourselves?
  2. Can your current system cost a batch?
  3. Who owns production scheduling on day one, and what will they use?
  4. Does your quality system already cover manufacturing deviations and release, or does it need to grow?
  5. Have you scoped the process work with the same seriousness as the facility work?
  6. What is your plan for the first batch that fails?
Where to start

Usually a process assessment.

Usually a process assessment, because the surface is broad and the interdependencies matter.

Where the immediate question is whether the current systems can carry it, a targeted analysis answers that in ten business days and often saves a much larger decision from being made on instinct. We can have an NDA signed the day you ask.

Start here

Scope the process work before the first batch.

Start a conversation